Site-specific cleavage of HCV genomic RNA and its cloned core and NS5B genes by DNAzyme.

作者: Deepak Kumar , Indrajit Chaudhury , Premashis Kar , Rakha H Das , None

DOI: 10.1111/J.1440-1746.2008.05717.X

关键词:

摘要: Background and Aims:  The 9600 nt hepatitis C virus (HCV) genomic RNA has only one internal ribosome entry site (IRES) for translation to a single polyprotein. In search of nucleic acid-based antiviral agents, two 10-23 DNAzymes were designed cleave the in IRES dependent polymerase (RDRP/NS5B) regions prevent replication HCV RNA. Methods: In vitro cleavage by specific DNAzyme, CDz NS5B NDz was carried out using synthesized runoff transcripts core genes. Cleavage mRNAs DNAzyme (Dz) HepG2 cells assessed reverse transcription chain reaction (RT-PCR) from co-transfected with cloned or gene its respective DNAzyme. Suppression protein expression due mRNA Dz determined Western blot analysis fluorescence intensity fluorescent-tagged expressed protein. Reduction activity enzymatic assays. Results:  cleaved their generated transcripts. Both expressions genes reduced substantially when Dz. RDRP accompanied enzyme activity. Increased cleavage, inhibition expression, reduction observed on increasing concentration. Conclusion:  Core targeted can be used controlling RNA.

参考文章(27)
R. Bartenschlager, V. Lohmann, J. O. Koch, Processing pathways of the hepatitis C virus proteins Journal of Hepatology. ,vol. 24, pp. 11- 19 ,(1996)
Birte Vester, Lykke H Hansen, Lars Bo Lundberg, B Ravindra Babu, Mads D Sørensen, Jesper Wengel, Stephen Douthwaite, Locked nucleoside analogues expand the potential of DNAzymes to cleave structured RNA targets. BMC Molecular Biology. ,vol. 7, pp. 19- 19 ,(2006) , 10.1186/1471-2199-7-19
Crispin R. Dass, Preclinical anticancer activity of DNA-based cleavage molecules. Drug Development and Industrial Pharmacy. ,vol. 32, pp. 1- 5 ,(2006) , 10.1080/03639040500387872
Birte Vester, Lars Bo Lundberg, Mads D. Sørensen, B. Ravindra Babu, Stephen Douthwaite, Jesper Wengel, LNAzymes: incorporation of LNA-type monomers into DNAzymes markedly increases RNA cleavage. Journal of the American Chemical Society. ,vol. 124, pp. 13682- 13683 ,(2002) , 10.1021/JA0276220
R. BHINDI, L. M. KHACHIGIAN, H. C. LOWE, DNAzymes targeting the transcription factor Egr‐1 reduce myocardial infarct size following ischemia–reperfusion in rats Journal of Thrombosis and Haemostasis. ,vol. 4, pp. 1479- 1483 ,(2006) , 10.1111/J.1538-7836.2006.02022.X
Guangxiang Luo, Robert K. Hamatake, Danielle M. Mathis, Jason Racela, Karen L. Rigat, Julie Lemm, Richard J. Colonno, De Novo Initiation of RNA Synthesis by the RNA-Dependent RNA Polymerase (NS5B) of Hepatitis C Virus Journal of Virology. ,vol. 74, pp. 851- 863 ,(2000) , 10.1128/JVI.74.2.851-863.2000
S. W. Santoro, G. F. Joyce, A General Purpose RNA-Cleaving DNA Enzyme Proceedings of the National Academy of Sciences of the United States of America. ,vol. 94, pp. 4262- 4266 ,(1997) , 10.1073/PNAS.94.9.4262
Gourav Mishra Gourav Mishra, Pooja Chadha Pooja Chadha, Indrajit Chaudhury Indrajit Chaudhury, RH Das, None, Inhibition of Autographa californica nucleopolyhedrovirus (AcNPV) polyhedrin gene expression by DNAzyme knockout of its serine/threonine kinase (pk1) gene. Virus Research. ,vol. 135, pp. 197- 201 ,(2008) , 10.1016/J.VIRUSRES.2008.02.002
Robert S. Brown, Paul J. Gaglio, Scope of worldwide hepatitis C problem. Liver Transplantation. ,vol. 9, ,(2003) , 10.1053/JLTS.2003.50244